Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

GW starts Canadian medicinal cannabis trials

Reuters

Tuesday 14 Aug 2001

---
LONDON, Aug 14 (Reuters) - GW Pharmaceuticals Plc, a British company
developing the world's first cannabis-based medicines for pain relief, said
on Tuesday it was starting clinical trials in Canada.
The Phase II trial -- the only one of its kind in North America -- will
take place under the supervision of Dr Daniel DeForge of the Rehabilitation
Centre, Ottawa Hospital. It will include suffers of multiple sclerosis,
spinal cord injury and other forms of chronic pain.

GW Pharma, which floated in London in June, already has an advanced trials
programme in Britain where its cannabis-based medicine entered final Phase
III tests on patients in May.

The Salisbury-based firm is developing prescription drugs to harness the
medicinal benefits of cannabis and has created a product which will be
delivered using an under-the-tongue spray.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!